Recent Quotes (30 days)

You have no recent quotes
chg | %

Verisante Technology Inc  

(Public, CVE:VRS)   Watch this stock  
Find more results for CVE:THZ
+0.0050 (33.33%)
Oct 20 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.01 - 0.02
52 week 0.01 - 0.04
Open 0.01
Vol / Avg. 0.00/30,665.00
Mkt cap 1.97M
P/E     -
Div/yield     -
EPS -0.01
Shares 98.62M
Beta 0.96
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin - -6218.14%
Operating margin - -6099.85%
EBITD margin - -2245.99%
Return on average assets -54.54% -57.62%
Return on average equity - -319.27%
Employees 8 -
CDP Score - -


2309 41st Ave W Suite 306
+1-604-6050507 (Phone)
+1-604-6050508 (Fax)

Website links


Verisante Technology, Inc. is a medical device company focusing on commercializing systems for the early detection of cancer. The Company's device, called the Verisante Aura can be used in the early detection of all forms of skin cancer, including basal cell and squamous cell carcinoma and melanoma. The Verisante Core device is based on the same platform technology as the Aura and can be used in the early detection of lung, cervical, gastrointestinal and colorectal cancers. Verisante Aura is a spectroscopy system designed to aid in the detection of skin cancer. This system provides information about the chemical composition of the skin non-invasively. Aura scans for different spectral markers. Verisante Core uses an endoscopic attachment to aid in the detection of lung, colon, cervical, and other cancers. It has completed a second Phase prototype of a rapid Multispectral Imaging camera (MSI) system for skin cancer detection.

Officers and directors

Thomas A. Braun President, Chief Executive Officer, Chief Business Development Officer, Director
Anna Trinh Chief Financial Officer, Vice President - Administration, Corporate Counsel, Secretary
Joseph Biegel Independent Director
Karen Boodram Independent Director
Age: 49
Christopher John Wesley Dennis Independent Director
Jake J. Thiessen Ph.D. Independent Director
Age: 66